Literature DB >> 2116214

Fulminant viral hepatitis.

E A Fagan1, R Williams.   

Abstract

In the United Kingdom and United States of America, fulminant viral hepatitis is due mainly to sporadic (non-parenteral) non-A, non-B hepatitis and hepatitis B whereas that caused by hepatitis A virus is very uncommon and by the herpes viruses remains rare. Recent advances in fulminant non-A, non-B hepatitis have come with the identification and cloning of a virus (27-34 nm) in the enteral variety (hepatitis E) which is prevalent in the Indian sub-continent, North Africa and elsewhere, especially in pregnant women. Virus-like particles (50-70 nm) with ultrastructural features similar to the togaviridae and flaviviridae have been identified in some patients with fulminant non-A, non-B hepatitis in the United Kingdom. The relation to hepatitis C virus, recently identified as a major cause of chronic post-transfusion (parenteral) non-A, non-B hepatitis, awaits serological analysis. The recent demonstration that persistence of active viral replication can occur in some cases of fulminant hepatitis types A and B using monoclonal antibody and molecular biology techniques challenges the classical views on the pathogenesis of these varieties of fulminant viral hepatitis.

Entities:  

Mesh:

Year:  1990        PMID: 2116214     DOI: 10.1093/oxfordjournals.bmb.a072410

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  7 in total

1.  The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries.

Authors:  K Das; A Jain; S Gupta; S Kapoor; R K Gupta; A Chakravorty; P Kar
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

2.  B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure.

Authors:  Patrizia Farci; Giacomo Diaz; Zhaochun Chen; Sugantha Govindarajan; Ashley Tice; Liane Agulto; Stefania Pittaluga; Denali Boon; Claro Yu; Ronald E Engle; Mark Haas; Richard Simon; Robert H Purcell; Fausto Zamboni
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

3.  A 7-day profile of oxidative stress and antioxidant status in patients with acute liver failure.

Authors:  Vikram Bhatia; Payal Bhardwaj; Jessina Elikkottil; Jyoti Batra; Anoop Saraya
Journal:  Hepatol Int       Date:  2008-09-16       Impact factor: 6.047

Review 4.  Acute liver failure.

Authors:  N K Arora; P Mathur; A Ahuja; A Oberoi
Journal:  Indian J Pediatr       Date:  2003-01       Impact factor: 1.967

Review 5.  Hepatitis C virus. A review.

Authors:  E Tang
Journal:  West J Med       Date:  1991-08

Review 6.  Sexually acquired hepatitis.

Authors:  M G Brook
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

Review 7.  Global distribution of infectious diseases requiring intensive care.

Authors:  Raul E Istúriz; Jaime Torres; José Besso
Journal:  Crit Care Clin       Date:  2006-07       Impact factor: 3.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.